Status:
UNKNOWN
In-depth ECG Analysis for the Extraction of Biomarkers of Cardiac Mechanical Dispersion
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Cardiovascular Pathology
Eligibility:
All Genders
50+ years
Brief Summary
Left ventricular systolic dysfunction (LVSD) refers to impaired contraction of the left ventricle, and can lead to heart failure and death. Early identification of LVSD, which often remains asymptomat...
Eligibility Criteria
Inclusion
- Person who has received full information on the organization of the research and has not objected to the use of this data;
- Age ≥ 50;
- Persons who have undergone an echocardiographic examination and a 12-lead ECG examination during consultations at the CHRU de Nancy;
- Persons with at least one cardiovascular risk (obesity, diabetes, hypertension, etc.).
Exclusion
- People with a history of heart disease (ischemic, valvular);
- Patients with significant 12-lead ECG abnormalities (complete bundle branch block, sequelae of myocardial infarction, etc.);
- ECG tracings or echocardiograms that cannot be analyzed.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06163911
Start Date
December 1 2023
End Date
June 1 2025
Last Update
December 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU Nancy
Vandœuvre-lès-Nancy, CHRU de Nancy, France, 54511